Enhancement of Oral Absorption in Selective 5-HT1DReceptor Agonists: Fluorinated 3-[3-(Piperidin-1-yl)propyl]indoles
- 30 June 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (15) , 2667-2670
- https://doi.org/10.1021/jm980204e
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Selective, Orally Active 5-HT1D Receptor Agonists as Potential Antimigraine AgentsJournal of Medicinal Chemistry, 1997
- Discrimination between drug candidates using models for evaluation of intestinal absorptionAdvanced Drug Delivery Reviews, 1997
- The chemical evolution of N,N-dimethyl-2-[5-(1,2,4-triazol-4-yl)-1H-indol-3-yl]ethylamine (L-741,604) and analogues: Potent and selective agonists for 5-HT1D receptorsBioorganic & Medicinal Chemistry Letters, 1996
- Design of drugs involving the concepts and theories of drug metabolism and pharmacokineticsMedicinal Research Reviews, 1996
- Inhibition of the Trigemino-Vascular System with 5-HT1D Agonist Drugs: Selectively Targeting Additional Sites of ActionEuropean Neurology, 1996
- Neurogenic Model of MigraineCephalalgia, 1995
- In vitro systems for studying intestinal drug absorptionMedicinal Research Reviews, 1995
- Intestinal Absorption of Dideoxynucleosides: Characterization Using a Multiloop in Situ TechniqueJournal of Pharmaceutical Sciences, 1995
- High regioselectivity in the alternative cleavage of terminal epoxides with different sources of nucleophilic fluorideJournal of Fluorine Chemistry, 1994
- Synthesis of chiral and bioactive fluoroorganic compoundsTetrahedron, 1993